First RCT using MolecuLight i:X technology
Addition of MolecuLight to standard treatment doubled 12-week healing rates of DFUs (204%) and improved wound closure
First RCT using MolecuLight i:X technology
Addition of MolecuLight to standard treatment doubled 12-week healing rates of DFUs (204%) and improved wound closure
1st study to describe healing outcomes of dehisced perineal wounds & factors associated with delayed healing
The presence of fluorescence significantly reduced the odds of wound healing in ≤ 4 weeks by 76%
23% increase in 12 week wound healing rate
33% decrease in antibiotic prescribing
47% decrease in antimicrobial spending per wound
25% decrease in wound area over 4 weeks with the elimination of bacterial fluorescence from wounds
A positive healing trajectory was associated with the implementation of fluorescence imaging (i:X)
All wounds where fluorescence signal from bacteria was eradicated healed within 2-6 weeks